Safety of treatment and dietary supplementation with diosmin in daily doses up to 2000 mg a day
Journal Title: New Medicine - Year 2016, Vol 20, Issue 3
Abstract
Introduction. diosmin is used to treat and alleviate the symptoms of venous insufficiency and haemorrhoids. diosmin-containing medicinal products have been available in poland since the 1990s with the status of drugs available on prescription in the form of flavonoid fraction containing diosmin, as a form subjected to micronisation or nonmicronised. for several years now, diosmin has been present on the pharmaceutical market in the form of over-the-counter medicines (otC), and dietary supplements containing diosmin are available not only in pharmacies, but also in other outlets. great availability of diosmin raises questions about the safety of a treatment without medical or pharmacist’s supervision. the safety of diosmin use in a daily dose of 2000 mg was confirmed in a double-blind, controlled placebo, randomised, three-arm and parallel, phase iii to evaluate the efficacy and safety of diosmin administered for 4 months in the treatment of cellulite. Aim. the aim of the study was to observe the efficacy and safety of micronised diosmin therapy used in a daily dose of 1000 and 2000 mg for a period of four months. Material and methods. the trial involved 327 patients aged 18 to 55 (mean 37.28, standard deviation of 8.587) meeting the inclusion criteria and not meeting the exclusion criteria. the safety analysis includes and shows in a table the measured parameters immediately prior to the first dose, after 2 and 4 months of therapy. Results. no statistically significant deviations from the standard condition in the following parameters present: complete blood count with differential, fibrinogen concentrations, alanine and aspartate transaminase concentration, urea and creatinine concentration, urinalysis. the therapy did not affect the value of systolic and diastolic blood pressure. no significant adverse actions in the studied groups. Conclusions. the results of a clinical trial cited in this work support the use of micronised diosmin in doses up to 2000 mg per day.
Authors and Affiliations
Agnieszka Staniewska
Keywords
Related Articles
- EP ID EP188106
- DOI -
- Views 112
- Downloads 0
The impact of rugby training on the spinal functional parameters
Aim. The aim of the present paper was to determine the impact of many years of rugby training on the formation of spinal curvatures and spinal sectional mobility.Material and methods. The research material constituted 20...
Correlation of trauma circumstances and mechanism with the type, localization and range of cranial and intracranial injuries in traffic accident casualties
A large number of traffic accident casualties are subjects to head traumas, causing difficulties in fast and correct diagnostics on site. It may lead to so called underdiagnosis and qualification of the case as ‘not urge...
Rare cause of subperiosteal abscess – a case report
Sinusitis occurs frequently in children. Foreign bodies, inserted randomly into nasal cavities might also be the cause of sinusitis in children. In our case, the foreign body obstructing causing the maxillary and ethmoid...
New bacterial zoonotic pathogens
The article presents the problem of new zoonotic bacterial pathogens posing a threat to humans. Currently, 11 pathogens responsible for causing human zoonotic diseases are being monitored by the European Union epidemiolo...
Reliability and validity of a new questionnaire for the assessment of nursing skills and knowledge in relation to transfusion therapy
Introduction. All medical staff members involved in transfusion therapy, have professional-, legal- and ethical responsibility for their own actions. Aim. This paper aims at reviewing nursing competencies assessing nurse...